0001181431-12-042742.txt : 20120730
0001181431-12-042742.hdr.sgml : 20120730
20120730184824
ACCESSION NUMBER: 0001181431-12-042742
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120726
FILED AS OF DATE: 20120730
DATE AS OF CHANGE: 20120730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huff Paul
CENTRAL INDEX KEY: 0001511459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 333-176897
FILM NUMBER: 12994841
MAIL ADDRESS:
STREET 1: C/O AMARIN PHARMA, INC.
STREET 2: MYSTIC PACKER BLDG., 12 ROOSEVELT AVENUE
CITY: MYSTIC
STATE: CT
ZIP: 06355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMARIN CORP PLC\UK
CENTRAL INDEX KEY: 0000897448
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL,
STREET 2: SHELBOURNE ROAD, BALLSBRIDGE
CITY: DUBLIN
STATE: L2
ZIP: 00000
BUSINESS PHONE: 353 1 6699 020
MAIL ADDRESS:
STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL,
STREET 2: SHELBOURNE ROAD, BALLSBRIDGE
CITY: DUBLIN
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC
DATE OF NAME CHANGE: 20000201
FORMER COMPANY:
FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC
DATE OF NAME CHANGE: 19930322
4
1
rrd351571.xml
FORM 4
X0306
4
2012-07-26
0
0000897448
AMARIN CORP PLC\UK
AMRN
0001511459
Huff Paul
C/O AMARIN PHARMA, INC.
1430 ROUTE 206, SUITE 200
BEDMINSTER
NJ
07921
0
1
0
0
Chief Commercial Officer
Ordinary Shares
2012-07-26
4
A
0
6950
0
A
6950
D
Ordinary Shares
2012-07-27
4
S
0
541
14.74
D
6409
D
Ordinary Shares
2012-07-27
4
S
0
6409
13.78
D
0
D
Restricted Stock Units
0
2012-07-26
4
A
0
6950
0
A
Ordinary Shares
6950
6950
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
On February 1, 2012, the Reporting Person was granted 41,700 restricted stock units (the "RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. The RSUs vest in six equal installments based on the Issuer's satisfaction of certain performance criteria and continued employment of the Reporting Person as provided in the Restricted Stock Unit Award Agreement between the Issuer and the Reporting Person. The performance criteria for the first installment was met, resulting in vesting of 6,950 RSUs.
These RSUs vest on July 26, 2013, subject to continued employment of the Reporting Person through such date. Ordinary Shares will be delivered to the Reporting Person as soon as practicable after the vesting date.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 4, 2012.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.32 to $14.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.32 to $13.50, inclusive.
/s/ Frederick Ahlholm, by power of attorney
2012-07-30